LEADER 05196nam 2200685 450 001 9910671337803321 005 20170919181831.0 010 $a1-4492-7200-2 035 $a(CKB)3710000000352653 035 $a(EBL)3227508 035 $a(OCoLC)923746518 035 $a(SSID)ssj0001492872 035 $a(PQKBManifestationID)11813575 035 $a(PQKBTitleCode)TC0001492872 035 $a(PQKBWorkID)11526573 035 $a(PQKB)10822957 035 $a(MiAaPQ)EBC3227508 035 $a(OCoLC)992073326 035 $a(FlNmELB)ELB38178 035 $a(EXLCZ)993710000000352653 100 $a20150306d2009 uy 0 101 0 $aspa 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 03$aEl Legislativo ante la gestio?n metropolitana /$fRoberto Eibenschutz Hartman, Ligia Gonzalez Garcia de Alba, coordinadores 210 1$aMe?xico D.F. :$cEditorial Miguel A?ngel Porru?a,$d[2009] 215 $a1 online resource (386 p.) 225 1 $aConocer para decidir. Serie El derecho 300 $aContiene i?ndice. 311 $a607-401-113-3 327 $aEL LEGISLATIVO ANTE LA GESTIO?N METROPOLITANA; PA?GINA LEGAL; I?NDICE; INTRODUCCIO?N; CIUDAD DE ME?XICO. METRO?POLIS Y REGIO?N CENTRO; La localizacio?n del nuevo aeropuerto de la Ciudad de Me?xico; El Libramiento Norte; Anillo transmetropolitano; Accesos carreteros; Tren elevado; Ferrocarril suburbano; Terminal intermodal de carga; Plantas de tratamiento de aguas negras; Disposicio?n y tratamiento de basura; Rescate del lago de Texcoco; Desarrollo Regional Integral Valle Tizayuca; Bibliografi?a; ZONA METROPOLITANA: REVISIO?N DEL CONCEPTO Y CRITERIOS DE DELIMITACIO?N; Propuestas de delimitacio?n en Me?xico 327 $aBibliografi?aEL RETO DE LEGISLAR Y ADMINISTRAR LAS ZONAS METROPOLITANAS Y EJEMPLOS INTERNACIONALES; Introduccio?n; Justificacio?n de los arreglos metropolitanos; Respuestas metropolitanas; Alternativas metropolitanas de corte consolidacionista; Modelos de gobernanza metropolitana sin gobierno metropolitano (conservar la fragmentacio?n); El federalismo como elemento clave para las respuestas metropolitanas; Acuerdos metropolitanos y poder; A manera de conclusio?n; Bibliografi?a; FORTALEZAS Y DEBILIDADES DEL MARCO LEGAL PARA LA ACCIO?N METROPOLITANA; Objetivos 327 $aAntecedentes y planteamiento del problemaEl marco juri?dico para la accio?n metropolitana; Legislacio?n; INSTRUMENTOS Y EXPERIENCIAS DE COORDINACIO?N METROPOLITANA EN ME?XICO. EL CASO DE PUEBLA-TLAXCALA; Introduccio?n; Antecedentes; El caso Puebla-Tlaxcala; Consideraciones; Bibliografi?a; INSTRUMENTOS Y EXPERIENCIAS DE COORDINACIO?N METROPOLITANA EN ME?XICO, EL CASO GUADALAJARA; Antecedentes; Estructura y funcionamiento del consejo metropolitano; El Fondo Metropolitano; Bibliografi?a; EL IMPLADE: HERRAMIENTA DE PLANEACIO?N URBANA EN LA ZONA METROPOLITANA DE VERACRUZ; Antecedentes; El IMPLADE 327 $aProceso legal de constitucio?nOperacio?n; Logros; Situacio?n actual; LA EXPERIENCIA DE PLANEACIO?N E INSTRUMENTACIO?N EN LA ZONA METROPOLITANA DEL VALLE DE ME?XICO; Enfoque de la Zona Metropolitana del Valle de Me?xico; Expresiones conceptuales y etapas del desarrollo regional y urbano nacional; Zona metropolitana, definicio?n y antecedentes; La Zona Metropolitana del Valle de Me?xico y la planeacio?n urbana; Marco juri?dico; El a?mbito normativo para el Distrito Federal; El a?mbito normativo para el Estado de Me?xico; En el a?mbito federal 327 $aOtras zonas metropolitanas (los casos de Barcelona, Guadalajara y Monterrey)Zona Metropolitana de Guadalajara (ZMG); Zona Metropolitana de Monterrey (ZMM); Experiencia de poli?ticas pu?blicas en la Zona Metropolitana del Valle de Me?xico (ZMVM); Conclusiones; Bibliografi?a; EL ESQUEMA FISCAL EN EL A?MBITO METROPOLITANO; Introduccio?n; El esquema fiscal como base para determinar las capacidades del gasto y la inversio?n pu?blicas; El esquema fiscal ""urbano"" frente a la ciudadani?a 327 $aGESTIO?N METROPOLITANA: LA IMPORTANCIA DE LAS INSTITUCIONES PARA EL DESARROLLO DE LAS CIUDADES EN LA ERA DE LA GLOBALIZACIO?N 410 0$aConocer para decidir. Serie El derecho. 606 $aRegional planning$zMexico 606 $aPlanificacio?n regional$zMe?xico 606 $aMetropolitan areas$zMexico 606 $aA?reas metropolitanas$zMe?xico 615 0$aRegional planning 615 4$aPlanificacio?n regional 615 0$aMetropolitan areas 615 4$aA?reas metropolitanas 676 $a307120972 702 $aEibenschutz Hartman$b Roberto 702 $aGonza?lez Garci?a de Alba$b Ligia 712 02$aUniversidad Auto?noma Metropolitana.$bUnidad Xochimilco. 712 02$aMe?xico.$bCongreso.$bCa?mara de Diputados.$bComisio?n de Desarrollo Metropolitano. 712 02$aUniversidad Auto?noma Metropolitana.$bPrograma Universitario de Estudios Metropolitanos. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910671337803321 996 $aEl Legislativo ante la gestio?n metropolitana$93055201 997 $aUNINA LEADER 01182aam a2200289 a 4500 001 991000835779707536 008 100906s 000 0 ita d 020 $a9788874611157 035 $ab13919258-39ule_inst 040 $aDip.to Filol. Ling. e Lett.$bita 245 03$aLa forma del libro :$bdal rotolo al codice (secoli III a.C.-XIX d.C.) /$ca cura di Franca Arduini ; con un saggio di Guglielmo Cavallo 260 $aFirenze :$bMandragora,$c2008 300 $a95 p. :$bill., facs. ;$c20 cm. 440 3$aLa biblioteca in mostra ;$v2 500 $aCatalogo della mostra tenuta presso la Biblioteca Medicea Laurenziana di Firenze, nel 2008 504 $aCon bibliografia e indice 650 4$aLibro$xStoria$vEsposizioni 650 4$aPapiri$vEsposizioni 650 4$aManoscritti$vEsposizioni 700 1 $aArduini, Franca 700 1 $aCavallo, Guglielmo 907 $a.b13919258$b28-01-14$c06-09-10 912 $a991000835779707536 945 $aLE008 FL.M. (Bibl.) A 77$g1$i2008000426729$lle008$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i15164366$z06-09-10 996 $aForma del libro$9226727 997 $aUNISALENTO 998 $ale008$b06-09-10$cm$da $e-$fita$git $h3$i0 LEADER 02355nam 2200565Ia 450 001 9910830420703321 005 20230721013412.0 010 $a1-118-21599-0 010 $a1-282-77288-0 010 $a9786612772887 010 $a0-470-43187-3 010 $a0-470-43184-9 035 $a(CKB)2670000000044315 035 $a(EBL)588923 035 $a(OCoLC)699474266 035 $a(SSID)ssj0000439587 035 $a(PQKBManifestationID)11925759 035 $a(PQKBTitleCode)TC0000439587 035 $a(PQKBWorkID)10464411 035 $a(PQKB)11583755 035 $a(MiAaPQ)EBC588923 035 $a(EXLCZ)992670000000044315 100 $a20080623d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aMicrochemical engineering in practice$b[electronic resource] /$fThomas R. Dietrich 210 $aHoboken, N.J. $cWiley$dc2009 215 $a1 online resource (509 p.) 300 $aDescription based upon print version of record. 311 $a0-470-23956-5 320 $aIncludes bibliographical references and index. 327 $aMicrochemical Engineering in Practice; CONTENTS; PREFACE; CONTRIBUTORS; I INTRODUCTION; II MICROFLUIDIC METHODS; III PERIPHERIC EQUIPMENT; IV MICROREACTION PLANTS; V APPLICATIONS; INDEX 330 $aMicrochemical Engineering in Practice provides the information chemists and engineers need to evaluate the use of microreactors, covering the technical, operational, and economic considerations for various applications. It explains the systems needed to use microreactors in production and presents examples of microreactor use in different chemistries, including larger scale production processes. There are guidelines on calculating the costs and the risks of production using continuous flow microreactors. Complete with case studies, this is an essential guide for chemists and engineers i 606 $aMicroreactors 606 $aMicrochemistry 615 0$aMicroreactors. 615 0$aMicrochemistry. 676 $a660.2832 676 $a660/.2832 700 $aDietrich$b Thomas R.$f1963-$01659257 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830420703321 996 $aMicrochemical engineering in practice$94013834 997 $aUNINA LEADER 04649nam 2201093z- 450 001 9910557595503321 005 20210501 035 $a(CKB)5400000000043722 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68283 035 $a(oapen)doab68283 035 $a(EXLCZ)995400000000043722 100 $a20202105d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aCharacterization and Clinical Management of Dilated Cardiomyopathy 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (232 p.) 311 08$a3-03943-761-5 311 08$a3-03943-762-3 330 $aDilated cardiomyopathy (DCM) is a particular phenotype of non-ischemic systolic heart failure, frequently recognizing a genetic background and affecting relatively young patients with few comorbidities. Nowadays, long-term survival of DCM patients has been markedly improved due to an early diagnosis and uninterrupted and tailored follow-up under constant optimal medical and non-pharmacological evidence-based treatments. Nevertheless, DCM is still one of the most common causes of heart transplantation in the western world. Clinical management requires an integrated and systematic use of diagnostic tools and a deeper investigation of the basic mechanisms underlying the disease. However, several emerging issues remain debated. Specifically, the genotype-phenotype correlation, the role of advanced imaging techniques and genetic testing, the lack of appropriate risk stratification models, the need for a multiparametric and multidisciplinary approach for device implantation, and a continuous reclassification of the disease during follow-up remain challenging issues in clinical practice. Therefore, the aim of this Special Issue is to shed the light on the most recent advancements in characterization and clinical management of DCM in order to unveil the conundrum of this particular disease. 606 $aMedicine$2bicssc 610 $aalternative splicing 610 $aarrhythmias 610 $aarrhythmic risk stratification 610 $aatrial fibrillation 610 $abiomarkers 610 $acalcium 610 $acardiac channelopathy 610 $acardiac magnetic resonance 610 $acardiac magnetic resonance imaging 610 $acardiac resynchronization therapy 610 $acardiac sodium channel 610 $acardiomyopathy 610 $acongenital heart disease 610 $acongestive heart failure 610 $adesmin 610 $adiastolic dysfunction 610 $adilated cardiomyopathy 610 $aDNA methylation 610 $aduchenne muscular distrophy 610 $aepigenetics 610 $agene therapy 610 $agenetics 610 $aheart 610 $aheart failure 610 $alaminopathy 610 $alate gadolinium enhancement 610 $aleft atrial strain 610 $aleft ventricle non-compaction cardiomyopathy 610 $aleft ventricle sphericity index 610 $aleft ventricular noncompaction 610 $aleft ventricular reverse remodelling 610 $aLMNA 610 $along axis strain 610 $along-term outcomes 610 $amajor adverse cardiovascular events 610 $amalignant ventricular arrhythmia 610 $amammalian target of rapamycin (mTOR) complex-1 610 $amdx 610 $amembrane stabilization 610 $amitochondrial dysfunction 610 $amuscular dystrophy 610 $amyopathy 610 $an/a 610 $anon-ischemic cardiomyopathy 610 $anon-sense mRNA decay 610 $anonischemic dilated cardiomyopathy 610 $aNT-proBNP 610 $aoxidative stress 610 $aphospholamban 610 $aphosphorylation 610 $aprecision medicine 610 $aRNA binding motif protein 20 (RBM20) 610 $asarcomere 610 $aSCN5A 610 $aSerca2a 610 $asex differences 610 $asupraventricular arrhythmia 610 $asystolic dysfunction 610 $atachycardiomyopathy 610 $atitin 610 $atroponin T 610 $aventricular arrhythmia 610 $awhole exome sequencing 615 7$aMedicine 700 $aMerlo$b Marco$4edt$01292384 702 $aMerlo$b Marco$4oth 906 $aBOOK 912 $a9910557595503321 996 $aCharacterization and Clinical Management of Dilated Cardiomyopathy$93022238 997 $aUNINA